中文
| Catalogue |
| Recommend Products |
Company News
- AMSBIO: Organoid Biobank for Predicting Cancer Patient Response to Drugs 5/27/2015
- AMSBIO:Xeno-Free and Endotoxin-Free Human Cytokines 5/4/2015
- Exclusive Biotinylated Protein Collection Specially Designed to Simplify Your Research 4/27/2015
- AMSBIO:Guide to Organoid Growth 4/1/2015
- AMSBIO: New tools and services for Immunotherapy discovery 3/20/2015
- AMSBIO: High Efficiency mRNA Delivery 3/3/2015
- AMSBIO: High Throughput PARP in vivo Pharmacodynamic Assay 2/27/2015
- AMSBIO: Novel Organoid Matrix Enables Long-Term Culture of Human Hepatocytes 2/2/2015
- AMSBIO: Specificity-Verified Monoclonal Antibodies 1/16/2015
- AMSBIO: Ebola Antigens and Antibodies for ELISA 12/19/2014
- AMSBIO: Highly Efficient Neuro Transfection Reagent 12/11/2014
- AMSBIO: Consistent Embryoid Body Formation and Differentiation from Stem Cells 12/2/2014
- AMSBIO Signs Agreement with Luxcel Biosciences to distribute Fluorescence-based Mitochondr... 11/13/2014
- AMSBIO: Next Generation Sequencing Library Sample Preparation Kits 10/27/2014
- AMSBIO:Blood-Derived Products for Personalised Medicine Research 10/20/2014
- AMSBIO: 3D Triculture Model for Evaluating Breast Cancer Progression 10/4/2014
- AMSBIO: Easy and Cost-Effective Generation of siRNAs from Full-Length Target Genes 9/25/2014
- AMSBIO: Easy-to-use, Quantitative Gamma-H2AX Assay 9/2/2014
- AMSBIO: Exquisite ‘Made-to-Measure’ Phospho-Specific Polyclonal Antibodies 8/21/2014
- AMSBIO: Cancer Conference Poster Prize Winner 7/24/2014